In a patient with candiduria who now presents with hematuria, what is the appropriate management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Candiduria with Hematuria

In a patient with candiduria who develops hematuria, immediately evaluate for pyelonephritis, fungus ball formation, or disseminated candidiasis—these require urgent imaging and systemic antifungal therapy, not just observation. 1

Critical Initial Assessment

The presence of hematuria in a candiduria patient fundamentally changes management because it suggests:

  • Invasive tissue infection (pyelonephritis or cystitis with mucosal invasion)
  • Fungus ball formation causing obstruction and bleeding
  • Possible disseminated candidiasis with renal involvement

Remove any indwelling bladder catheter immediately if feasible—this is strongly recommended regardless of symptoms 1. The catheter perpetuates infection and prevents clearance.

Diagnostic Workup

Obtain urgent imaging with CT or ultrasound to evaluate for:

  • Hydronephrosis or urinary obstruction
  • Fungus balls (aggregations of mycelia and yeasts)
  • Renal abscesses
  • Emphysematous pyelonephritis 1

These structural complications preclude successful treatment with antifungals alone and may require surgical intervention 1, 2.

Do not rely on pyuria or colony counts to differentiate infection from colonization—these are unreliable in catheterized patients 1. The hematuria itself, combined with candiduria, is your clinical indicator.

Treatment Algorithm

For Fluconazole-Susceptible Species (C. albicans)

Treat as symptomatic pyelonephritis:

  • Oral fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks 1
  • This is a strong recommendation with low-quality evidence

For Fluconazole-Resistant Species (C. glabrata, C. krusei)

Use amphotericin B deoxycholate:

  • 0.3-0.6 mg/kg IV daily for 1-7 days 1
  • With or without flucytosine 25 mg/kg PO four times daily for 2 weeks 1
  • Flucytosine monotherapy (25 mg/kg four times daily for 2 weeks) is an alternative for C. glabrata 1

Critical caveat: Lipid formulations of amphotericin B do NOT achieve adequate urine concentrations and should be avoided for urinary tract infections 1. Only amphotericin B deoxycholate is effective.

If Fungus Ball Identified

Surgical intervention is strongly recommended 1:

  • Endoscopic removal of the fungal bezoar
  • Relief of obstruction with ureteral stent or percutaneous nephrostomy
  • Irrigation through nephrostomy tubes with amphotericin B deoxycholate 25-50 mg in 200-500 mL sterile water 1
  • Continue systemic antifungals as above until symptoms resolve and cultures clear 3, 2

Special Considerations

If patient is neutropenic or very low birth weight infant (<1500g): Treat as candidemia with systemic therapy, not just as urinary tract infection 1. These high-risk patients require:

  • Echinocandin or fluconazole (depending on prior exposure and local resistance patterns)
  • Longer duration of therapy
  • Evaluation for disseminated disease

Eliminate urinary tract obstruction if present—this is strongly recommended 1. Consider removal or replacement of nephrostomy tubes or stents if feasible.

Bladder irrigation with amphotericin B (50 mg/L sterile water daily for 5 days) may be useful for fluconazole-resistant cystitis, but has high relapse rates and is generally discouraged except for refractory cases 1.

Common Pitfalls

Do NOT use echinocandins or azoles other than fluconazole for urinary tract candidiasis—they achieve minimal urinary concentrations and are ineffective 1, 4.

Do NOT assume hematuria is from anticoagulation alone—pursue full evaluation even if patient is on antiplatelet or anticoagulant therapy 5. The combination of candiduria and hematuria warrants investigation.

Do NOT treat asymptomatic candiduria without hematuria—but hematuria changes this calculus by indicating tissue invasion 1.

The key distinction: hematuria transforms candiduria from likely colonization into probable infection requiring treatment and imaging to exclude serious complications like fungus balls or pyelonephritis.

Related Questions

In a male patient with a contaminated urine specimen (numerous squamous epithelial cells) and candiduria, what is the appropriate management, including repeat specimen collection and empiric antibiotic therapy?
In a 54-year-old woman presenting with initial urinary tract infection symptoms and a urine culture growing 3,000 colony‑forming units per milliliter yeast, should she be treated for candiduria or for a typical bacterial urinary tract infection?
In a patient with an indwelling Foley catheter who has budding yeast and hyphae on urine microscopy, what is the appropriate management?
In a 77-year-old long‑term care resident with uncontrolled diabetes and a urinalysis showing turbid urine, pH 5.5, trace protein, 4+ glucose, 11–20 white blood cells per high‑power field, trace bacteria, and a few budding yeast but no urinary symptoms, should I treat the candiduria or start empiric antibiotics?
What is the recommended treatment for candiduria?
In a patient with thyrotoxicosis who remains hyperthyroid despite carbimazole 100 mg daily, what is the next step in management?
What is the appropriate treatment for candiduria (budding yeast) in a female patient?
How should neurological adverse effects associated with tigecycline be managed?
What is the safest and most effective sleep aid for adults with bipolar disorder?
With red blood cell count (RBC) 5.94, mean corpuscular volume (MCV) 79.0, mean corpuscular hemoglobin (MCH) 24.7, mean corpuscular hemoglobin concentration (MCHC) 31.3, and red cell distribution width (RDW) 16.5, what laboratory tests should be ordered next?
What is the appropriate treatment for a patient with a positive rapid plasma reagin (RPR) indicating syphilis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.